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The microbial colonization of the intestine during the first months of life constitutes the most important
process for the microbiota-induced host-homeostasis. Alterations in this process may entail a high-risk for
disease in later life. However, the potential factors affecting this process in the infant are not well known.
Moreover, the potential impact of orally administered vaccines upon the establishing microbiome remains
unknown. Here we assessed the intestinal microbiome establishment process and evaluated the impact of
rotavirus vaccination upon this process. Metagenomic, PCR-DGGE and faecal short chain fatty acids
analyses were performed on faecal samples obtained from three infants before and after the administration
of each dose of vaccine. We found a high inter-individual variability in the early life gut microbiota at
microbial composition level, but a large similarity between the infants’ microbiomes at functional level.
Rotavirus vaccination did not show any major effects upon the infant gut microbiota. Thus, the individual
microbiome establishment and development process seems to occur in a defined manner during the first
stages of life and rotavirus vaccination appears to be inconsequential for this process.
T
he basis of a healthy intestinal microbiota lies in the early neonatal period with the initial steps of estab-
lishment of this complex microbial ecosystem1. Microbial colonization of the gut in human newborns is
started by facultative anaerobes which contribute to the establishment and development of strict anaerobic
bacterial populations by reducing oxygen content2. Different factors including mode of delivery, feeding habits,
gestational age or use of medication have been reported to affect this process3,4. The initial microbial colonization
has been shown to constitute the most important moment for the microbiota-induced host-homeostasis. This
microbe-host interaction in early life is necessary for a proper maturation of the immune system5,6, and results
essential for a normal host development and physiology7,8. Therefore, during this relatively unstable and sensitive
initial period any alteration in the microbiota development process may increase the risk of disease in later life1,9.
After weaning the complexity and diversity of the microbiota increases rapidly and at the age of 2–3 years the
infant microbiota reaches an adult-like composition10.
The delivery mode11,12, gestational age13,14,15,16 or antibiotics administration14,17,18,19 are known to affect the
microbiota composition. Nevertheless, the impact of other factors, such as other medical interventions in early
life, on the process of establishment of the intestinal microbiota in newborns still remains poorly understood as
most of the currently available studies have focused on the adult population20. Moreover, most of the studies
carried out using modern next-generation-sequencing techniques have applied 16S rRNA gene-sequencing for
microbiota analyses whilst few works have assessed the total infant metagenome composition10,20,21,22. To this
regard, metagenomic analyses have the advantage of providing not only data at microbial composition level, such
as 16S rRNA gene data, but also data on the functions present in the metagenome. Furthermore, most reports on
the infant microbiome have evaluated the effect of delivery mode, feeding habits, gestational age or disease,
whereas the impact of some common early life medical interventions on the establishing intestinal microbiota
remains largely unknown.
Nowadays, vaccination is a very common practice in developed countries. Among the different vaccines some
are orally administered and contain attenuated microorganisms or viruses, such as the one for rotavirus, a double
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expected to interact with intestinal immune cells eliciting an immune
response at mucosal level. Therefore, such vaccination may have the
potential for modifying the intestinal environment, thus altering the
establishing infant gut microbiome.
The aim of the present study was to assess the process of estab-
lishment of the intestinal microbiome in infants and to evaluate the
potential impact of oral rotavirus vaccination upon this process. To
this end, total metagenomic analyses, in combination with PCR-
DGGE and faecal short chain fatty acids (SCFA) determinations,
were performed.
Results
PCR-DGGE. In spite of the changes observed over-time, the PCR-
DGGE results showed clearly different profiles for the three infants
(Figure 1). In addition, nomajor changes in the DGGE patterns were
evidenced when the samples taken before administration of each
rotavirus vaccine dose were compared with those obtained after
administration of the vaccine dose.
The DGGE pattern obtained for infant 2 showed less bands
than those obtained for the other two infants, suggesting a less
complex microbiota (Figure 1). Moreover, the profile of the infant
2 remained largely unchanged during the study with a predom-
inant band that could not be un-ambiguously identified but
belonging to the phylum Proteobacteria (the highest homology
scores were all obtained with different proteobacteria). Faeces
from infant 1 showed initially (first sample, 2 months) a strong
band corresponding to Bacteroides, with a band identified as
Streptococcus becoming the strongest one at the second sampling
point. The samples of the third infant presented a clear band along
the sampling period, likely corresponding to proteobacteria, with
bands from anaerobes such as Bacteroides and Bifidobacterium
becoming apparent in the second and third sampling points (4
and 6 months).
Short chain fatty acids. The SCFA profiles were found to be very
stable and not affected by the vaccination, with molar proportions of
the three major SCFA (acetic, propionic and butyric) showing little
variation along time and among individuals (Supplementary Figure
S1). The acetic acid was the most abundant SCFA in the three infants
along the study, followed by propionate and then butyrate.
Metagenomic analyses.Metagenomic data showed clear differences
in microbiota composition among infants, with all the samples from
the same infant clustering together and independently of those of the
other infants (Figure 2, Supplementary Figure S2). These differences
point to the individual as themain factor determining themicrobiota
composition; clear differences were found, at genus level, among the
intestinal microbiota of the three babies, although their respective
microbiotas showed limited variability over time and an almost
negligible vaccination-effect.
These results indicate that the vaccine hadminimal or no effect on
the individual microbiota profile. Thus, in order to assess the micro-
biome evolution during the first months of life in these three babies
we calculated, in each infant and sampling point (vaccine dose), the
mean of the relative proportion for each bacterial group obtained
before and after vaccine. Microbial composition at different taxo-
nomic levels showed clear differences among infants (Figure 3 and
Supplementary Figure S3). At genus level Bacteroides dominated in
the first sample of infant 1 (2 months of age) with Bifidobacterium
becoming the dominant genus at later sampling points (3 and 4
months of age). The microbiota of infant 2 was dominated by enter-
obacteria, mainly Escherichia, during the whole sampling period
whilst in the case of infant 3 enterobacteria dominated at the first
two sampling points (up to 4 months of age), with Bifidobacterium
becoming dominant later on.
Vaccination showed no effects on a-diversity or gene richness
(data not shown). In general, infant 1 displayed higher a-diversity
than infants 2 and 3 (Table 1). Diversity and gene richness increased
Figure 1 | PCR-DGGE faecal microbiota profiles obtained before and after (b or a) each rotavirus vaccination dose (D1, D2 and D3) from each infant.
Numbers indicate the results of the species identification of the corresponding DGGE band.
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over time in infants 1 and 2 but remained almost unchanged in infant
3 (Table 1).
Regarding the functional features of the infants microbiome the
KEGG level B categories ‘‘enzyme families’’, ‘‘membrane transport’’,
‘‘carbohydrate metabolism’’ and ‘‘amino acid metabolism’’ were the
most represented ones in all the infants and samples analysed
(Figure 3).The metagenomes showed higher stability and lower vari-
ability at functional level than at microbial composition (genus) level
(Figure 3 and Supplementary Figure S2). Nevertheless, PCoA ana-
lysis of functional data still clustered together the different samples
belonging to each infant (Supplementary Figure S4). When spear-
man correlation distances were calculated using either KEGG (levels
B or C) or composition at genus level, it became clear that the dis-
tances among samples were lower for KEGG data (Figure 4) than for
the genera data. This corroborated the greater similarity of infant
metagenomes at functional than at microbial composition level.
Discussion
The process of intestinal colonization by microorganisms during the
postnatal period is very important for later health8,9,23. Therefore,
controlling or minimizing the impact of early life medical interven-
tions on the establishing gut microbiome may have a large influence
in later health. Unfortunately, our knowledge on the gut microbiome
establishment process in the neonatal gut and the effect of perinatal
medical interventions upon this process is still limited.
Some vaccines such as the one for rotavirus are administered
orally and will interact with the intestinal mucosa whichmaymodify
the intestinal environment and, therefore, may affect the intestinal
microbiome establishment process. To this regard, norovirus infec-
tion in adults did not showmajor effects on the intestinal microbiota
in themajority of patients, although in aminority of casesmicrobiota
alterations were observed24. Nevertheless, the impact of other viruses
causing enteric infections or that of orally administered vaccines
against them remains largely unknown. Garcı´a-Lo´pez and co-work-
ers25 used 16S rRNA gene-based analysis to compare the microbiotas
of rotavirus vaccinated and unvaccinated children after one year of
age (12–15 months) without observing any long-term microbiota
differences. In the present study we have used total metagenome
analyses to test whether vaccination against rotavirus affected the
process of establishment of the intestinal microbiota in infants at
the time of vaccination.
Although the limited number of infants does not allow estab-
lishing firm conclusions, our PCR-DGGE and metagenomic ana-
lyses of the intestinal microbiota of the three infants participating
in the study suggest that rotavirus vaccination has no significant
effect upon the establishing gut microbiome. In general, our
results on microbial composition are in the range of previously
reported data for healthy neonates26–30. A significant presence of
bifidobacteria (Actinobacteria) was evidenced in the faeces of the
two breast-fed infants participating in the study whilst the levels of
this microbial group were lower in the formula-fed infant, who
presented higher levels of Proteobacteria than the breast-fed
babies during the first months of life. This is in contrast to the
dominance of Bacteroidetes and Firmicutes occurring in adults31–34.
In spite of the microbiota changes over time we found clearly
differentiated individual profiles, with the samples obtained at
different times for each infant clustering together. This suggests
a predominant role of the individual over the age on determining
the gut microbiome during the first months of life and supports
data previously obtained by 16S rDNA sequencing showing high
inter-individual microbiota variability in neonates29.
In this area, most of the studies performed so far have used 16S
rRNA gene-based analyses of the intestinal microbiota of full-term
newborns but only a few works have assessed the total metagenome
composition in these infants10,20,21. To this regard, our results shed
some light on the still limited knowledge of the gut microbiome
establishment process, indicating that the inter-individual micro-
biome shows higher similarity at functional than at microbial com-
position level. This is also supported by the limited inter-individual
variability in faecal metabolites such as SCFA.
To sumup, although the limited sample size precludes establishing
definitive conclusions, the present work underlines a high inter-indi-
vidual variability in the gut microbiota composition and evolution at
early life. However, this relatively large microbial community divers-
ity renders few differences between the infants’ microbiomes at func-
tional level. Moreover, the individual microbiome establishment and
development process seems to occur in a defined manner during the
first stages of life and it is not affected by oral rotavirus vaccination.
Methods
Volunteers. The study was approved by the Regional Ethical Committee of Asturias
Public Health Service (SESPA) and carried out in accordance with the approved
guidelines of the Ethics Committee. Written informed consent was obtained from the
parents. The study included three Caucasian male infants. Infant 2 was delivered by
caesarean section and receivedmixed feeding (breast-milk and infant formula) whilst
the other two infants (1 and 3) were vaginally delivered and exclusively breast-fed.
The three infants received the rotavirus vaccine ‘‘RotaTeqH’’ (Sanofi Pasteur MSD,
Lyon, France) which contains attenuated viruses and it is orally administered in three
doses during the first sixmonths of life. Infants 1 and 2 received the three doses at 7–8,
11–12 and 15–16 weeks of life, whereas infant 3 received them at 8, 16 and 24weeks of
life.
Faecal Sample Collection and DNA extraction. Faecal samples were collected the
day before and the day after (between 24 and 48 hours) the administration of each
dose of vaccine. Fresh faecal samples were immediately frozen. For DNA
extraction faecal samples were weighed, diluted 1/10 in sterile PBS solution, and
homogenized in a LabBlender 400 stomacher (Seward Medical, London, UK) at
full-speed for 4 min. The homogenate (1 mL) was then centrifuged and the
supernatant obtained was filtered and frozen at 220uC for SCFA analyses. The
DNA was extracted from the faecal pellet using the QIAamp DNA stool kit
(Qiagen GmbH, Hilden, Germany) following the manufacturer’s specifications as
previously described14. The extracted DNA was kept frozen (270uC) until
analysis.
SCFA Analysis. The analysis of SCFA was carried out in a chromatographic system
composed of a 6890NGC (Agilent Technologies Inc., Palo Alto, CA, USA) connected
to a FID and a MS 5973N detector as described previously14.
Denaturing Gradient Gel electrophoresis (DGGE). The profile of the dominant
microbial populations in faeces at the different sampling points was determined by
PCR-DGGE. PCR-DGGE reaction mixture, conditions and universal primers
Figure 2 | PCoA analysis of the microbiota composition at genus level
obtained from faecal samples before and after (b or a) each rotavirus
vaccination dose (D1, D2 andD3) from each infant. PCoAwas performed
with Spearman correlation distance.
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previously described (357F; TACGGGAGGCAGCAG and 518R;
ATTACCGCGGCTGCTGG)were used35. PCR products were separated by DGGE in
a DCode system (BioRad Laboratories) in a 30% to 60% gradient of urea-formamide
in Tris-Acetate-EDTA (TAE) buffer (pH8). Selected bands were excised from gels
and submitted to a new PCR reaction with the same PCR-DGGE primers without the
GC clamp. After purification, the amplified PCR products were sequenced in a
capillar ABI3730XL DNA Analyzer (Macrogen Europe, Amsterdam, Netherland)
and partially identified by comparison (BLAST) with data held in the GenBank
database35.
Metagenomic analyses. DNA Sequencing. The extracted faecal DNA (5 mg) was
precipitated by standard sodium acetate/ethanol precipitation, submitted to Zhejiang
California International Nanosystems Institute (ZCNI, Hangzhou, Zhejiang, China)
for library processing and sequenced at BGI (Shezhen, China). Three out of the
eighteen samples did not render enough DNA, for the other fifteen samples the
libraries were constructed (500 bp insert size, with adapter) and a 23 101 Pair-End
sequencing strategy was carried out in a Hiseq 2000 sequencing platform (Illumina).
CASAVA-1.8.2 was used for base calling with default parameters except –mismatches
1 -mask y100n, I6n, Y10n – adapter-sequence.
Figure 3 | Main faecal microbial groups at genus level (A) and gene functional annotations at KEGG level 2 (B) determined from the metagenomic
analyses of the samples obtained at different time points from each infant.
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Raw Data Processing. The quality control on the pair-end sequenced reads was
conducted using the following criteria; i) reads withmore than 3 ambiguous bases (N)
were removed, ii) reads with adapters’ sequences at both ends were discarded, iii) if in
one readmore than 50 bases presented low quality (Q2) the read was discarded, iv) no
more than 15 bases at 39 end of reads would be trimmed if ambiguous bases or bases
with low quality (Q2) occurred and v) when one of the paired-end reads did not
passed the control, although its mate may have passed, then the whole pair was
discarded.
Assembly, Gene prediction, gene set construct and annotation. We use Soap De novo
version 2.04 to perform a genome assembly36 and Glimmer 3.02 to predict genes37. To
construct a non-redundant gene set the method introduced by Qin and co-workers32
was used. Non-redundant genes were annotated by KAAS system with SBH mode38.
Abundance profiles of organisms and genes. SOAP aligner version 2.21 was used for
aligning the pair-end reads against reference genomes and non-redundant genes
(parameters ‘‘-r 2 -M 4 -m 100 -x 2000’’). Then, the methods described by Arumugan
and co-workers33 were applied to generate abundance profiles of microorganisms and
genes.
KEGG Function abundance profile. Each gene was assigned into only one KEGG
orthologous group, then the abundance of genes was accounted as abundance of their
common unique KEGG orthologous. When a KEGG orthologous belonged to dif-
ferent KEGG functional features at B level or C level its abundance was added to all the
relative KEGG functional categories to which the orthologous belonged.
a-diversity and gene richness calculations. Chao1, Shannon and Simpson indices were
determined with the R program package ‘‘vegan’’ (Oksanen et al. 2013, Vegan:
Community Ecology Package 2.0-10. http://cran.r-project.org/web/packages/vegan/
index.html). To calculate gene richness we parsed the gene abundance profile and
then counted number of observed genes as gene richness.
b-diversity calculations. We used Spearman correlation distance as our b-diversity
determination, first we calculated samples’s spearman coefficient S, then distance
matrix M was calculated by 1 - S. This was determined with the following command
‘‘,- 1 – cor (X, method5 ‘‘spearman’’)’’ in R, where X is profile of KEGG or Genera
composition.We usedWilcoxon rank sum to test if two distance sets differs from each
other. PCoA analysis was performed by R library ‘‘ade4’’39.
Nucleotide sequence accession numbers. The raw sequences reported in this article
have been deposited in the EMBL European Nucleotide Archive (accession number
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